pCF525-EF1a-Hygro-P2A-mCherry-lenti Citations (3)

Originally described in: Systematic discovery of natural CRISPR-Cas12a inhibitors.
Watters KE, Fellmann C, Bai HB, Ren SM, Doudna JA Science. 2018 Oct 12;362(6411):236-239. doi: 10.1126/science.aau5138. Epub 2018 Sep 6. PubMed Journal

---

Articles Citing pCF525-EF1a-Hygro-P2A-mCherry-lenti

Articles
Structural basis for AcrVA4 inhibition of specific CRISPR-Cas12a. Knott GJ, Cress BF, Liu JJ, Thornton BW, Lew RJ, Al-Shayeb B, Rosenberg DJ, Hammel M, Adler BA, Lobba MJ, Xu M, Arkin AP, Fellmann C, Doudna JA. Elife. 2019 Aug 9;8. pii: 49110. doi: 10.7554/eLife.49110. PubMed
Transplantation of miPSC/mESC-derived retinal ganglion cells into healthy and glaucomatous retinas. Oswald J, Kegeles E, Minelli T, Volchkov P, Baranov P. Mol Ther Methods Clin Dev. 2021 Mar 10;21:180-198. doi: 10.1016/j.omtm.2021.03.004. eCollection 2021 Jun 11. PubMed
Contemporary human H3N2 influenza A viruses require a low threshold of suitable glycan receptors for efficient infection. Spruit CM, Sweet IR, Maliepaard JCL, Bestebroer T, Lexmond P, Qiu B, Damen MJA, Fouchier RAM, Reiding KR, Snijder J, Herfst S, Boons GJ, de Vries RP. Glycobiology. 2023 Oct 30;33(10):784-800. doi: 10.1093/glycob/cwad060. PubMed

If you have published an article using this material, please email us at to have your article added to this page.